BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32077118)

  • 21. Suppressed rate of carcinogenesis and decreases in tumour volume and lung metastasis in CXCL14/BRAK transgenic mice.
    Hata R; Izukuri K; Kato Y; Sasaki S; Mukaida N; Maehata Y; Miyamoto C; Akasaka T; Yang X; Nagashima Y; Takeda K; Kiyono T; Taniguchi M
    Sci Rep; 2015 Mar; 5():9083. PubMed ID: 25765541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CXCL14 inhibits trophoblast outgrowth via a paracrine/autocrine manner during early pregnancy in mice.
    Kuang H; Chen Q; Fan X; Zhang Y; Zhang L; Peng H; Cao Y; Duan E
    J Cell Physiol; 2009 Nov; 221(2):448-57. PubMed ID: 19626669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expression of chemokine CXCL14 in primary osteosarcoma and its association with prognosis].
    Lu J; Wang J; Yong B; Song G; Zhao Z; Tang Q; Zou C; Yin J; Xie X; Shen J
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):798-803. PubMed ID: 23803187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemokine (C-X-C motif) ligand 14 contributes to lipopolysaccharide-induced fibrogenesis in mouse L929 fibroblasts via modulating PPM1A.
    Li L; Li Q; Wei L; Wang Z; Ma W; Liu F; Shen Y; Zhang S; Zhang X; Li H; Qian Y
    J Cell Biochem; 2019 Aug; 120(8):13372-13381. PubMed ID: 30920024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemokine CXCL14; a double-edged sword in cancer development.
    Gowhari Shabgah A; Haleem Al-Qaim Z; Markov A; Valerievich Yumashev A; Ezzatifar F; Ahmadi M; Mohammad Gheibihayat S; Gholizadeh Navashenaq J
    Int Immunopharmacol; 2021 Aug; 97():107681. PubMed ID: 33932697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cytokine gene CXCL14 restricts human trophoblast cell invasion by suppressing gelatinase activity.
    Kuang H; Chen Q; Zhang Y; Zhang L; Peng H; Ning L; Cao Y; Duan E
    Endocrinology; 2009 Dec; 150(12):5596-605. PubMed ID: 19833716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Expression of the Chemokine CXCL14 Correlates with Several Aggressive Aspects of Glioblastoma and Promotes Key Properties of Glioblastoma Cells.
    Fazi B; Proserpio C; Galardi S; Annesi F; Cola M; Mangiola A; Michienzi A; Ciafrè SA
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31117166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of CXCL14 (BRAK) expression in prostate cancer.
    Schwarze SR; Luo J; Isaacs WB; Jarrard DF
    Prostate; 2005 Jun; 64(1):67-74. PubMed ID: 15651028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells.
    Barbaria EM; Kohl B; Buhren BA; Hasenpusch-Theil K; Kruse F; Küry P; Martini R; Müller HW
    Neurobiol Dis; 2009 Mar; 33(3):448-58. PubMed ID: 19111616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The chemokine CXCL14 is negatively associated with obesity and concomitant type-2 diabetes in humans.
    Cereijo R; Quesada-López T; Gavaldà-Navarro A; Tarascó J; Pellitero S; Reyes M; Puig-Domingo M; Giralt M; Sánchez-Infantes D; Villarroya F
    Int J Obes (Lond); 2021 Mar; 45(3):706-710. PubMed ID: 33414488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxia-induced CXC chemokine ligand 14 expression drives protumorigenic effects through activation of insulin-like growth factor-1 receptor signaling in glioblastoma.
    Wei ST; Chiang JY; Wang HL; Lei FJ; Huang YC; Wang CC; Cho DY; Hsieh CH
    Cancer Sci; 2023 Jan; 114(1):174-186. PubMed ID: 36106406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CXCL14 Overexpression Attenuates Sepsis-Associated Acute Kidney Injury by Inhibiting Proinflammatory Cytokine Production.
    Lv J; Wu ZL; Gan Z; Gui P; Yao SL
    Mediators Inflamm; 2020; 2020():2431705. PubMed ID: 32317861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of C-X-C motif chemokine ligand 14 promoter region DNA methylation and single nucleotide polymorphism in influenza A severity.
    Chen L; Lei Y; Zhang L
    Respir Med; 2021; 185():106462. PubMed ID: 34082276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CXCL14 antagonizes the CXCL12-CXCR4 signaling axis.
    Hara T; Tanegashima K
    Biomol Concepts; 2014 May; 5(2):167-73. PubMed ID: 25372750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pro-inflammatory cytokines and CXC chemokines as game-changer in age-associated prostate cancer and ovarian cancer: Insights from preclinical and clinical studies' outcomes.
    Ullah A; Chen Y; Singla RK; Cao D; Shen B
    Pharmacol Res; 2024 Jun; 204():107213. PubMed ID: 38750677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of CXC chemokine ligand 14 exacerbates collagen-induced arthritis.
    Chen L; Guo L; Tian J; He H; Marinova E; Zhang P; Zheng B; Han S
    J Immunol; 2010 Apr; 184(8):4455-9. PubMed ID: 20212097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CXCL14, a Brown Adipokine that Mediates Brown-Fat-to-Macrophage Communication in Thermogenic Adaptation.
    Cereijo R; Gavaldà-Navarro A; Cairó M; Quesada-López T; Villarroya J; Morón-Ros S; Sánchez-Infantes D; Peyrou M; Iglesias R; Mampel T; Turatsinze JV; Eizirik DL; Giralt M; Villarroya F
    Cell Metab; 2018 Nov; 28(5):750-763.e6. PubMed ID: 30122557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CXCL14 is no direct modulator of CXCR4.
    Otte M; Kliewer A; Schütz D; Reimann C; Schulz S; Stumm R
    FEBS Lett; 2014 Dec; 588(24):4769-75. PubMed ID: 25451233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of tumour-suppressing chemokine BRAK/CXCL14 reduces cell migration rate of HSC-3 tongue carcinoma cells and stimulates attachment to collagen and formation of elongated focal adhesions in vitro.
    Sato K; Ozawa S; Izukuri K; Kato Y; Hata R
    Cell Biol Int; 2010 Apr; 34(5):513-22. PubMed ID: 20067447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems.
    Kouzeli A; Collins PJ; Metzemaekers M; Meyrath M; Szpakowska M; Artinger M; Struyf S; Proost P; Chevigne A; Legler DF; Eberl M; Moser B
    Front Immunol; 2020; 11():561404. PubMed ID: 33123134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.